Market Overview:
The global diabetic foot ulcers treatment market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of diabetes, rising awareness about diabetic foot ulcers (DFUs), and technological advancements in wound care dressings and therapy devices. Based on type, the global diabetic foot ulcers treatment market is segmented into wound care dressings and biologics. The wound care dressing segment is further divided into foam dressings, hydrocolloid dressing, hydrogel dressing, alginate dressing, and other dressings. The biologics segment is further divided into growth factors and skin grafts/skin substitutes. Based on application, the global diabetic foot ulcers treatment market is segmented into hospital settings, clinics settings ambulatory surgical center (ASC) settings,, homecare setting,. Based on region,, North America dominates the global diabetic foot ulcers treatment market followed by Europe., Asia Pacificis projected to grow at a highest CAGR during forecast period owing to increase in prevalence of diabetes coupled with rising awareness about DFUs.
Product Definition:
Diabetic foot ulcers are a common complication of diabetes. They can develop as a result of nerve damage, poor circulation, and/or infection. Left untreated, they can lead to serious health problems, including amputation. Treatment for diabetic foot ulcers usually includes antibiotics to treat any infection, wound care to clean and heal the wound, and sometimes surgery. The importance of treatment for diabetic foot ulcers is that it can prevent more serious health complications from developing.
Wound Care Dressings (Foam dressings, Hydrocolloid Dressing, Hydrogel Dressing, Alginate Dressing, and Other Dressings):
Wound care dressings are used for treating chronic and acute wounds. The global wound care dressing market is expected to witness significant growth over the forecast period owing to increasing prevalence of chronic diseases such as diabetes, cancer, and other autoimmune diseases coupled with rising geriatric population across the globe. Moreover, technological advancements in wound dressing products are also anticipated to boost market growth during the forecast period.
Biologics (Growth factors, and Skin Graft and Skin Substitute):
Biologics is the new term used for growth factors and skin grafts and skin substitutes. Growth factors are proteins that are naturally produced by the body to promote healing.
Application Insights:
On the basis of application, the global diabetic foot ulcers treatment market is segmented into hospital, clinics, ambulatory surgical center and homecare setting. The hospital segment dominated the market in 2017 owing to availability of advanced healthcare facilities and skilled medical staff at a global level. In addition, presence of various government initiatives that support research for new ulcer treatments at a domestic level further propels growth in this segment. For instance, Ministry of Health & Family Welfare (India) promotes ¢â‚¬Å“Swachh Bharat Mission¢â‚¬ which aims to make India completely free from open defecation by 2019 through several programs such as construction of toilets and installation of sewage systems at a domestic level which eventually results in improvement in hygiene conditions across the country thereby supporting ulcer treatment procedures over there.
Regional Analysis:
North America dominated the global diabetic foot ulcers treatment market in 2017. This can be attributed to the presence of a large number of key players, high awareness levels about early diagnosis and effective treatment, availability of advanced therapies for wound care management, and supportive reimbursement framework in this region. In addition, rising incidence rates for diabetes are also expected to contribute towards market growth during the forecast period. Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to improving healthcare infrastructure & facilities along with increasing prevalence rate for diabetes within this region.
The Asia Pacific regional market is likely to exhibit significant growth due its developing economy coupled with increasing disposable income & consumerism resulting into growing demand for technologically advanced medical products such as biologics and devices used in treating wounds infections which includes dressings among others).
Growth Factors:
- Increasing incidence of diabetes: The increasing incidence of diabetes is the major growth driver for the diabetic foot ulcers treatment market. According to the World Health Organization (WHO), in 2015, around 415 million people were living with diabetes and this number is expected to increase to 642 million by 2030. This will create a large pool of patients who are at risk for developing diabetic foot ulcers, thereby driving the demand for diabetic foot ulcers treatment products.
- Rising awareness about diabetic foot ulcers: There is a growing awareness among people about the risks associated with untreated or poorly treated diabetic foot ulcers. This is leading to an increased demand for effective and safe treatments for these lesions, which in turn is propelling the growth of the global diabetic foot ulcers treatment market.
- Technological advancements in wound care products: The technological advancements in wound care products are providing new and innovative solutions for treating various types of wounds, including diabetic foot ulcers. This is resulting in an increased adoption rate of these products, thereby driving market growth.
Scope Of The Report
Report Attributes
Report Details
Report Title
Diabetic Foot Ulcers Treatment Market Research Report
By Type
Wound Care Dressings (Foam dressings, Hydrocolloid Dressing, Hydrogel Dressing, Alginate Dressing, and Other Dressings), Biologics (Growth factors, and Skin Graft and Skin Substitute), Therapy Devices (Negative pressure wound devices, Hyperbaric Oxygen therapy devices, and Other Therapy Devices)
By Application
Hospital, Clinics, Ambulatory Surgical Center, Homecare Setting
By Companies
3M Healthcare, Coloplast A/S, B.Braun Melsungen AG, Acelity L.P. Inc, Smith & Nephew Plc, Medtronic Plc, ConvaTec Inc, Molnlycke Health Care, Organogenesis, Inc., Derma Sciences Inc., 3M Healthcare
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
210
Number of Tables & Figures
147
Customization Available
Yes, the report can be customized as per your need.
Global Diabetic Foot Ulcers Treatment Market Report Segments:
The global Diabetic Foot Ulcers Treatment market is segmented on the basis of:
Types
Wound Care Dressings (Foam dressings, Hydrocolloid Dressing, Hydrogel Dressing, Alginate Dressing, and Other Dressings), Biologics (Growth factors, and Skin Graft and Skin Substitute), Therapy Devices (Negative pressure wound devices, Hyperbaric Oxygen therapy devices, and Other Therapy Devices)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinics, Ambulatory Surgical Center, Homecare Setting
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 3M Healthcare
- Coloplast A/S
- B.Braun Melsungen AG
- Acelity L.P. Inc
- Smith & Nephew Plc
- Medtronic Plc
- ConvaTec Inc
- Molnlycke Health Care
- Organogenesis, Inc.
- Derma Sciences Inc.
- 3M Healthcare
Highlights of The Diabetic Foot Ulcers Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Wound Care Dressings (Foam dressings, Hydrocolloid Dressing, Hydrogel Dressing, Alginate Dressing, and Other Dressings)
- Biologics (Growth factors, and Skin Graft and Skin Substitute)
- Therapy Devices (Negative pressure wound devices, Hyperbaric Oxygen therapy devices, and Other Therapy Devices)
- By Application:
- Hospital
- Clinics
- Ambulatory Surgical Center
- Homecare Setting
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diabetic Foot Ulcers Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no one-size-fits-all answer to this question, as the best treatment for diabetic foot ulcers will vary depending on the individual's specific situation and health condition. However, some general tips that may be helpful include: • Taking regular breaks from standing or walking; sitting or lying down instead can help reduce swelling and pain in feet • Applying a cold pack or ice to feet regularly for relief from pain and inflammation • Using over-the-counter medications such as ibuprofen (Advil, Motrin) or acetaminophen (Tylenol) to relieve pain and inflammation • Elevating feet when possible to reduce swelling • Seeking medical attention if symptoms worsen, including increased pain, redness, warmth sensation around the ankle area
Some of the key players operating in the diabetic foot ulcers treatment market are 3M Healthcare, Coloplast A/S, B.Braun Melsungen AG, Acelity L.P. Inc, Smith & Nephew Plc, Medtronic Plc, ConvaTec Inc, Molnlycke Health Care, Organogenesis, Inc., Derma Sciences Inc., 3M Healthcare.
The diabetic foot ulcers treatment market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Diabetic Foot Ulcers Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Diabetic Foot Ulcers Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Diabetic Foot Ulcers Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Diabetic Foot Ulcers Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Diabetic Foot Ulcers Treatment Market Size & Forecast, 2020-2028
4.5.1 Diabetic Foot Ulcers Treatment Market Size and Y-o-Y Growth
4.5.2 Diabetic Foot Ulcers Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Wound Care Dressings (Foam dressings
5.2.2 Hydrocolloid Dressing
5.2.3 Hydrogel Dressing
5.2.4 Alginate Dressing
5.2.5 and Other Dressings)
5.2.6 Biologics (Growth factors
5.2.7 and Skin Graft and Skin Substitute)
5.2.8 Therapy Devices (Negative pressure wound devices
5.2.9 Hyperbaric Oxygen therapy devices
5.2.10 and Other Therapy Devices)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinics
6.2.3 Ambulatory Surgical Center
6.2.4 Homecare Setting
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Diabetic Foot Ulcers Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Diabetic Foot Ulcers Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Wound Care Dressings (Foam dressings
9.6.2 Hydrocolloid Dressing
9.6.3 Hydrogel Dressing
9.6.4 Alginate Dressing
9.6.5 and Other Dressings)
9.6.6 Biologics (Growth factors
9.6.7 and Skin Graft and Skin Substitute)
9.6.8 Therapy Devices (Negative pressure wound devices
9.6.9 Hyperbaric Oxygen therapy devices
9.6.10 and Other Therapy Devices)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinics
9.10.3 Ambulatory Surgical Center
9.10.4 Homecare Setting
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Wound Care Dressings (Foam dressings
10.6.2 Hydrocolloid Dressing
10.6.3 Hydrogel Dressing
10.6.4 Alginate Dressing
10.6.5 and Other Dressings)
10.6.6 Biologics (Growth factors
10.6.7 and Skin Graft and Skin Substitute)
10.6.8 Therapy Devices (Negative pressure wound devices
10.6.9 Hyperbaric Oxygen therapy devices
10.6.10 and Other Therapy Devices)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinics
10.10.3 Ambulatory Surgical Center
10.10.4 Homecare Setting
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Wound Care Dressings (Foam dressings
11.6.2 Hydrocolloid Dressing
11.6.3 Hydrogel Dressing
11.6.4 Alginate Dressing
11.6.5 and Other Dressings)
11.6.6 Biologics (Growth factors
11.6.7 and Skin Graft and Skin Substitute)
11.6.8 Therapy Devices (Negative pressure wound devices
11.6.9 Hyperbaric Oxygen therapy devices
11.6.10 and Other Therapy Devices)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinics
11.10.3 Ambulatory Surgical Center
11.10.4 Homecare Setting
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Wound Care Dressings (Foam dressings
12.6.2 Hydrocolloid Dressing
12.6.3 Hydrogel Dressing
12.6.4 Alginate Dressing
12.6.5 and Other Dressings)
12.6.6 Biologics (Growth factors
12.6.7 and Skin Graft and Skin Substitute)
12.6.8 Therapy Devices (Negative pressure wound devices
12.6.9 Hyperbaric Oxygen therapy devices
12.6.10 and Other Therapy Devices)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinics
12.10.3 Ambulatory Surgical Center
12.10.4 Homecare Setting
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Wound Care Dressings (Foam dressings
13.6.2 Hydrocolloid Dressing
13.6.3 Hydrogel Dressing
13.6.4 Alginate Dressing
13.6.5 and Other Dressings)
13.6.6 Biologics (Growth factors
13.6.7 and Skin Graft and Skin Substitute)
13.6.8 Therapy Devices (Negative pressure wound devices
13.6.9 Hyperbaric Oxygen therapy devices
13.6.10 and Other Therapy Devices)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinics
13.10.3 Ambulatory Surgical Center
13.10.4 Homecare Setting
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Diabetic Foot Ulcers Treatment Market: Competitive Dashboard
14.2 Global Diabetic Foot Ulcers Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 3M Healthcare
14.3.2 Coloplast A/S
14.3.3 B.Braun Melsungen AG
14.3.4 Acelity L.P. Inc
14.3.5 Smith & Nephew Plc
14.3.6 Medtronic Plc
14.3.7 ConvaTec Inc
14.3.8 Molnlycke Health Care
14.3.9 Organogenesis, Inc.
14.3.10 Derma Sciences Inc.
14.3.11 3M Healthcare
